Global Medical REIT Inc has a consensus price target of $7.6, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from B. Riley Securities, B. Riley Securities, and Baird on May 8, 2023, March 6, 2023, and October 10, 2022. With an average price target of $7.67 between B. Riley Securities, B. Riley Securities, and Baird, there's an implied -5.23% downside for Global Medical REIT Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
05/08/2023 | GMRE | Buy Now | Global Medical REIT | $8.09 | 35.97% | B. Riley Securities | Bryan Maher | $12 → $11 | Maintains | Buy | Get Alert |
03/06/2023 | GMRE | Buy Now | Global Medical REIT | $8.09 | 48.33% | B. Riley Securities | Bryan Maher | $14 → $12 | Maintains | Buy | Get Alert |
10/10/2022 | GMRE | Buy Now | Global Medical REIT | $8.09 | — | Baird | Amanda Sweitzer | — | Downgrade | Outperform → Neutral | Get Alert |
10/06/2022 | GMRE | Buy Now | Global Medical REIT | $8.09 | 11.25% | BMO Capital | John Kim | $13 → $9 | Downgrade | Outperform → Market Perform | Get Alert |
01/13/2022 | GMRE | Buy Now | Global Medical REIT | $8.09 | — | Keybanc | Jordan Sadler | — | Downgrade | Overweight → Sector Weight | Get Alert |
09/20/2021 | GMRE | Buy Now | Global Medical REIT | $8.09 | 110.14% | Keybanc | Jordan Sadler | — | Initiates | → Overweight | Get Alert |
07/09/2021 | GMRE | Buy Now | Global Medical REIT | $8.09 | 122.5% | Colliers Securities | Barry Oxford | — | Initiates | → Buy | Get Alert |
The latest price target for Global Medical REIT (NYSE: GMRE) was reported by B. Riley Securities on May 8, 2023. The analyst firm set a price target for $11.00 expecting GMRE to rise to within 12 months (a possible 35.97% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Global Medical REIT (NYSE: GMRE) was provided by B. Riley Securities, and Global Medical REIT maintained their buy rating.
There is no last upgrade for Global Medical REIT.
The last downgrade for Global Medical REIT Inc happened on October 10, 2022 when Baird changed their price target from N/A to N/A for Global Medical REIT Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on May 8, 2023 so you should expect the next rating to be made available sometime around May 8, 2024.
While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a maintained with a price target of $12.00 to $11.00. The current price Global Medical REIT (GMRE) is trading at is $8.09, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.